NCT02375867View on ClinicalTrials.gov

Steroids in Fulminant Hepatitis A in the Pediatric Age Group

PHASE4CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

August 31, 2017

Study Completion Date

September 30, 2017

Conditions
Fulminant Hepatic Failure
Interventions
DRUG

prednisolone

Oral administration of 1 mg/Kg/day

DRUG

methylprednisolone

Intravenous injection of 0.8 mg/kg/day

Trial Locations (1)

32511

National Liver Institute, Menoufia

All Listed Sponsors
collaborator

Quesna Central Hospital, Ministry Of Health, Egypt

UNKNOWN

lead

National Liver Institute, Egypt

OTHER

NCT02375867 - Steroids in Fulminant Hepatitis A in the Pediatric Age Group | Biotech Hunter | Biotech Hunter